Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$55,692,848
-$9,199,947 QoQ
Shares Held
2,312,826
+0.1% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#165
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. PFE ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
This page
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,692,848 | 2,312,826 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $64,892,795 | 2,310,997 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $55,557,974 | 2,231,244 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $58,154,099 | 2,282,343 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $58,045,806 | 2,394,629 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $70,991,808 | 2,801,571 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $79,314,458 | 2,989,614 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $96,339,668 | 3,328,945 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $89,611,629 | 3,202,703 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $181,087,148 | 6,525,663 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $176,819,224 | 6,141,689 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $235,191,916 | 7,090,501 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $266,741,580 | 7,272,126 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $341,019,904 | 8,358,331 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $418,077,509 | 8,159,202 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $302,192,686 | 6,905,683 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $361,904,417 | 6,902,621 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $355,394,732 | 6,864,878 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $418,109,252 | 7,080,597 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $303,715,930 | 7,061,519 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $269,232,204 | 6,875,184 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $246,526,562 | 6,804,487 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $243,966,998 | 6,627,737 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $233,066,422 | 6,350,590 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $202,457,222 | 6,191,346 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $188,915,265 | 5,787,853 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||